145 related articles for article (PubMed ID: 8550047)
1. Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease.
Mathurin P; Vidaud D; Vidaud M; Bedossa P; Paradis V; Ratziu V; Chaput JC; Poynard T
Hepatology; 1996 Jan; 23(1):44-51. PubMed ID: 8550047
[TBL] [Abstract][Full Text] [Related]
2. Age-associated decreases in the messenger ribonucleic acid level and the rate of synthesis of apolipoprotein A-II in murine senile amyloidosis.
Kitagawa K; Naiki H; Takeda T; Higuchi K
Lab Invest; 1994 Apr; 70(4):565-71. PubMed ID: 8176896
[TBL] [Abstract][Full Text] [Related]
3. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
4. [Decrease ApoB/ApoA-1 ratio and cardiovascular risk improvement: a tadalafil pleiotropic effect? Preliminary study on healthy volunteers].
Roumeguère T; Zouaoui Boudjeltia K; Hauzeur C; Ramal A; Schulman C; Vanhaeverbeek M; Ducobu J; Wespes E
Prog Urol; 2008 Dec; 18(13):1087-91. PubMed ID: 19041816
[TBL] [Abstract][Full Text] [Related]
5. Effects of hepatic HDL-related mRNAs on plasma prebeta HDL in cholesterol-fed rabbits.
Sugano M; Makino N; Yanaga T
Artery; 1997; 22(4):182-205. PubMed ID: 9576025
[TBL] [Abstract][Full Text] [Related]
6. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Matthan NR; Welty FK; Barrett PH; Harausz C; Dolnikowski GG; Parks JS; Eckel RH; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
8. Does alpha-1-proteinase inhibitor play a protective role in coronary atherosclerosis?
Stakisaitis D; Basys V; Benetis R
Med Sci Monit; 2001; 7(4):701-11. PubMed ID: 11433198
[TBL] [Abstract][Full Text] [Related]
9. Apolipoproteins A-I and B-markers in coronary risk evaluation.
Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
[TBL] [Abstract][Full Text] [Related]
10. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
Sabino AP; De Oliveira Sousa M; Moreira Lima L; Dias Ribeiro D; Sant'Ana Dusse LM; Das Graças Carvalho M; Fernandes AP
Transl Res; 2008 Sep; 152(3):113-8. PubMed ID: 18774540
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for pure steatosis in alcoholic patients.
Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.
Wozniak MA; Itzhaki RF; Faragher EB; James MW; Ryder SD; Irving WL;
Hepatology; 2002 Aug; 36(2):456-63. PubMed ID: 12143056
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.
Lackner KJ; Monge JC; Gregg RE; Hoeg JM; Triche TJ; Law SW; Brewer HB
J Clin Invest; 1986 Dec; 78(6):1707-12. PubMed ID: 3782476
[TBL] [Abstract][Full Text] [Related]
14. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B/apolipoprotein A-I ratio: reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study.
Leiviskä J; Sundvall J; Alfthan G; Jauhiainen M; Salomaa V
Clin Chim Acta; 2011 May; 412(11-12):1146-50. PubMed ID: 21419755
[TBL] [Abstract][Full Text] [Related]
16. Life style habits such as alcohol consumption and physical activity in relation to serum apoB / apoA-I ratio amongst 64-year-old women with varying degrees of glucose tolerance.
Simonsson M; Schmidt C; Sigurdadottir V; Helenius ML; Fagerberg B
J Intern Med; 2007 Nov; 262(5):537-44. PubMed ID: 17908159
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of liver Galbeta1, 4GlcNAc alpha2, 6-sialyltransferase gene by ethanol significantly correlates with alcoholic steatosis in humans.
Gong M; Castillo L; Redman RS; Garige M; Hirsch K; Azuine M; Amdur RL; Seth D; Haber PS; Lakshman MR
Metabolism; 2008 Dec; 57(12):1663-8. PubMed ID: 19013288
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
19. ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.
Dirisamer A; Stadler A; Bucek RA; Widhalm K
Acta Paediatr; 2006 Jul; 95(7):810-3. PubMed ID: 16801176
[TBL] [Abstract][Full Text] [Related]
20. Increased apoB/apoA-I ratio is predictive of peripheral arterial disease in initially healthy 58-year-old men during 8.9 years of follow-up.
Johansson L; Schmidt C
Angiology; 2009; 60(5):539-45. PubMed ID: 19022789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
